Substitution [idcn]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Oral [spco]
Estrogen [horm, phsu, strd]
Progestin [horm, phsu, strd]
therapy [ftcn]
postmenopausal [tmco]
Women [popg]
effects [qlco]
Hypertriglyceridaemia [fndg]
Objective [inpr]
investigated [ftcn]
effects [qlco]
Changing [ftcn]
Oral [spco]
Estrogen [horm, phsu, strd]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Lipid [lipd]
Lipoprotein [aapp, bacs]
Profile [lbpr]
postmenopausal [tmco]
Women [popg]
Hypertriglyceridaemia [fndg]
serum concentration [qnco]
mg dl [qnco]
estrogen therapy [topp]
Progestin [horm, phsu, strd]
Design [acty]
One [qnco]
postmenopausal [tmco]
Japanese [popg]
Women [popg]
Receive [qlco]
mg% [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
mg% [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
Daily [tmco]
months [tmco]
serum triglyceride [lbpr]
Concentrations [menp]
mg dl [qnco]
months [tmco]
treatment [ftcn]
Six [qnco]
Chosen [acty]
Study [mnob]
Assigned [ftcn]
RANDOM [resa]
Group [idcn]
Continued [idcn]
Oral [spco]
Regimen [topp]
Changed [ftcn]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Continuing [idcn]
mg% [qnco]
Oral [spco]
medroxyprogesterone acetate [horm, phsu, strd]
months [tmco]
N NOS [aapp, imft]
blood lipids [lipd]
Compared [acty]
Group [idcn]
Result [ftcn]
serum concentration [qnco]
Triglyceride [bacs, lipd]
very low density lipoprotein triglyceride [aapp, bacs, lipd]
Decreased [qnco]
Changing [ftcn]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Triglyceride [bacs, lipd]
mg dl [qnco]
P NOS [aapp, imft]
Seen [qlco]
Concentrations [menp]
Low Density Lipoprotein Cholesterol [bacs, strd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Conclusion [idcn]
Changing [ftcn]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Triglyceride Metabolism [moft]
Women [popg]
Hypertriglyceridaemia [fndg]
Oral [spco]
estrogen therapy [topp]
Progestin [horm, phsu, strd]
Minimal [qlco]
Effect [qlco]
Cholesterol [bacs, strd]
Profile [lbpr]
